EDIUNET Free equity investment tool of Japanese companies

Companies Cart
@
Credit Rating Analysis
Annual
First quarter
Second quarter
Third quarter
Sponsored Link
Related Company
@ VLC HOLDINGS
@ ビーコンインフォメーションテクノロジー
@ D.Western Therapeutics Institute
@ e-まちタウン
@ WILSON LEARNING WORLDWIDE
@ TL Holdings
@ ICHINEN HOLDINGS
@ コムシード
@ J-Holdings
@ CellSeed
@ KYOWA ENGINEERING CONSULTANTS
@ INSPIRE
@ AIREX.
@ アプリックスIPホールディングス
@ ブイシンク
EDIUNET Related Ranking
EDIUNET
EDIUNET Credit Rating
EDIUNET Industry Avg
EDIUNET Prefectures
Yuho! Industry
EDIUNET Rating News
Prev « 2024-04 » Next
Mon Tue Wed Thu Fri Sat Sun
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
-
15
-
16
-
17
-
18
-
19
-
20
-
21
-
22
-
23
-
24
-
25
-
26
-
27
-
28
-
29
-
30
-
[Update list]
1/28 Retail Trade (CAWACHI:A etc...
1/27 Banks (The Awa Bank:BBB→A)
1/23 Chemicals (Milbon:AA→AAA)
1/21 Glass & Ceramics Products (..
1/21 Machinery (TSUDAKOMA:C)
1/21 Other Services (Netindex.:CC)
1/20 Other Products (Kurogane Kos..
1/20 Wholesale Trade (リーバイ・..
1/20 Other Services (川崎地質:BB→..
1/17 Chemicals (Kawaguchi Chemica..
 RSS
 Company RSS
 Daily RSS
Sponsored Link
Recently Download Chart
ROHM
graph
日本アビオニクス
graph
日本アビオニクス
graph
日本アビオニクス
graph
メルコホールディングス
graph

Credit Rating Analysis: D.Western Therapeutics Institute (Annual )

The details of credit rating (bankruptcy risk) can be checked. A credit rating in nine stages (AAA-C).

【Analysis Menu】 @Outline @Statement @Rating @Indicator @Download

Sponsored Link

Credit Rating (Bankruptcy Risk): D.Western Therapeutics Institute (Annual ) Non-Consolidated

Date Credit Rating Comment Sales Current Profit Net Income
2012-12-31  BB  Credit is a little enough, but be insufficient potential by biz environs. ¥ 112 M
460.00%
¥ -255 M
27.76%
¥ -256 M
27.68%

Financial Timeline

Date  2012-12-31 
(Annual )
 2013-03-31 
(First quarter )
 2013-06-30 
(Second quarter )
 2013-09-30 
(Third quarter )
Credit Rating BBBBBBBB
Total Assets
¥ 1 B
¥ 1 B
¥ 1 B
¥ 2 B
Net Assets
¥ 452 M
¥ 755 M
¥ 775 M
¥ 2 B

Financial Statement Risk Analysis: D.Western Therapeutics Institute (Annual ) (Non-Consolidated )

Special note
Net income is minus 4 consecutive terms. The business have very high risk.
Operating cash flow minus 4 consecutive terms. The business have very high risk.
Net Assets have dropped 4 consecutive terms. The fiscal base is getting worse.
Cash(¥ 423 M) is more than the total liabilities(¥ 15 M). It is a very steady fiscal base!
[Date: 2012-12-31]  Danger : Warning : Caution : Good
Management Risk (*Cumulative loss)
Earned Surplus etc. (¥ -874 M) is minus, so Cumulative loss , there is a possibility that the management situation is severe.
Management Risk (*Net Income & Operating Cash Flow is minus or 0 )
Net Income(¥ -256 M) & Operating Cash Flow (¥ -264 M) is minus or 0, so , there is a possibility that the management situation is very severe.
Financing Risk (*Issuance of new shares)
Investment Cash Flow (¥ 99 M) is a plus, Issuance of new shares (¥ 69 M) is plus. Because it is thought that the circulating fund is gained by sale and new issue of stocks of stock property , there is a possibility that the financing is severe.
Financing Risk (*Financial Cash Flow is plus )
Operating Cash Flow (¥ -264 M) is a minus, Financial Cash Flow (¥ 68 M) is a plus. Because sale is inactive, it may depend for financing on loan from banks, capital increase, etc.
Financing Risk (*Sale of stock property)
Operating Cash Flow (¥ -264 M) is minus, Investment Cash Flow (¥ 99 M) is plus. Because the main occupation was dull, stock property may have been sold off.
[Date: 2011-12-31]  Danger : Warning : Caution : Good
Management Risk (*Cumulative loss)
Earned Surplus etc. (¥ -652 M) is minus, so Cumulative loss , there is a possibility that the management situation is severe.
Management Risk (*Net Income & Operating Cash Flow is minus or 0 )
Net Income(¥ -354 M) & Operating Cash Flow (¥ -343 M) is minus or 0, so , there is a possibility that the management situation is very severe.
Financing Risk (*Issuance of new shares)
Investment Cash Flow (¥ 398 M) is a plus, Issuance of new shares (¥ 24 M) is plus. Because it is thought that the circulating fund is gained by sale and new issue of stocks of stock property , there is a possibility that the financing is severe.
Financing Risk (*Financial Cash Flow is plus )
Operating Cash Flow (¥ -343 M) is a minus, Financial Cash Flow (¥ 22 M) is a plus. Because sale is inactive, it may depend for financing on loan from banks, capital increase, etc.
Financing Risk (*Sale of stock property)
Operating Cash Flow (¥ -343 M) is minus, Investment Cash Flow (¥ 398 M) is plus. Because the main occupation was dull, stock property may have been sold off.
Non-performing asset Risk (*Accounts Receivable and Inventory, etc. confirmed content)
Other Current Assets (¥ 27 M) is Net Income (¥ -354 M) Operating Cash Flow (¥ -343 M) is a minus, Sales (¥ 20 M) more , there is a possibility of holding the non-performing asset.
[Date: 2010-12-31]  Danger : Warning : Caution : Good
Management Risk (*Cumulative loss)
Earned Surplus etc. (¥ -312 M) is minus, so Cumulative loss , there is a possibility that the management situation is severe.
Management Risk (*Net Income & Operating Cash Flow is minus or 0 )
Net Income(¥ -418 M) & Operating Cash Flow (¥ -406 M) is minus or 0, so , there is a possibility that the management situation is very severe.
Management Risk (*Net Income is decrease )
Net Income (¥ -418 M) is first term Net Income (¥ -392 M) less , there is a possibility that the management situation has stagnated and deteriorated
Financing Risk (*Financial Cash Flow is plus )
Operating Cash Flow (¥ -406 M) is a minus, Financial Cash Flow (¥ 90 K) is a plus. Because sale is inactive, it may depend for financing on loan from banks, capital increase, etc.
Non-performing asset Risk (*Accounts Receivable and Inventory, etc. confirmed content)
Other Current Assets first term ratio (¥ 12 M) is Sales first term ratio (-) more , there is a possibility that the non-performing asset was increased.
Non-performing asset Risk (*Accounts Receivable and Inventory, etc. confirmed content)
Other Current Assets (¥ 26 M) is Net Income (¥ -418 M) Operating Cash Flow (¥ -406 M) is a minus, Sales (-) more , there is a possibility of holding the non-performing asset.
Overinvestment Risk (*Intangible Assets confirmed content)
Operating Cash Flow (¥ -406 M) and Investment Cash Flow (¥ -3 M) is minus, so , there is a possibility of the overinvestment.
[Date: 2009-12-31]  Danger : Warning : Caution : Good
Management Risk (*Net Income & Operating Cash Flow is minus or 0 )
Net Income(¥ -392 M) & Operating Cash Flow (¥ -316 M) is minus or 0, so , there is a possibility that the management situation is very severe.
Financing Risk (*Financial Cash Flow is plus )
Operating Cash Flow (¥ -316 M) is a minus, Financial Cash Flow (¥ 1 B) is a plus. Because sale is inactive, it may depend for financing on loan from banks, capital increase, etc.
Non-performing asset Risk (*Accounts Receivable and Inventory, etc. confirmed content)
Other Current Assets (¥ 13 M) is Net Income (¥ -392 M) Operating Cash Flow (¥ -316 M) is a minus, Sales (-) more , there is a possibility of holding the non-performing asset.
Overinvestment Risk (*Intangible Assets confirmed content)
Operating Cash Flow (¥ -316 M) and Investment Cash Flow (¥ -698 M) is minus, so , there is a possibility of the overinvestment.

Related Information: D.Western Therapeutics Institute (Annual )

Statement Type
Annual : D.Western Therapeutics Institute
First quarter : D.Western Therapeutics Institute
Second quarter : D.Western Therapeutics Institute
Third quarter : D.Western Therapeutics Institute
Analysis Menu
@Outline : D.Western Therapeutics Institute
@Statement : D.Western Therapeutics Institute
@Rating : D.Western Therapeutics Institute
@Indicator : D.Western Therapeutics Institute
@Download : D.Western Therapeutics Institute
Industry Comparison Ranking
Other Services - EDIUNET Industry Rankings
Other Services - EDIUNET Credit Rating
Other Services - EDIUNET Industry Avg
Comparison with a neighboring company
Aichi - EDIUNET Prefectures
Aichi名古屋市 - EDIUNET Prefectures

Related company's newest statement

Date Company Credit Rating Date
1/21 Netindex. CC 2013-11-30
1/20 川崎地質 BB→BBB 2013-11-30
1/20 KYOWA ENGINEERING CONSU.. B→BB 2013-11-30
1/20 KG Intelligence AAA→AA 2013-12-20
1/16 アクトコール -→B 2013-11-30
1/16 S-Pool C→CC 2013-11-30
1/16 T&C HOLDINGS C 2013-11-30
1/15 HITO -→AAA 2013-11-30 (Q1)
1/15 Pasona Group CC 2013-11-30 (Q2)
1/15 乃村工藝社 BB→BBB 2013-11-30 (Q3)

Ticker Market Industry Month report Rating
@ D.Western Therapeutics Institute 4576 OSE JASDAQ Other Services 12 Annual BB

Related Company

@ AIREX. (Sales ¥ 2 B)
@ TL Holdings (Sales ¥ 104 M)
@ KYOWA ENGINEERING CONSULTANTS (Sales ¥ 4 B)
@ Kenedix (Sales -)
@ J-Holdings (Sales ¥ 179 M)
@ WILSON LEARNING WORLDWIDE (Sales ¥ 1 B)
@ NowLoading. (Sales ¥ 16 M)
@ ICHINEN HOLDINGS (Sales ¥ 2 B)
@ D.Western Therapeutics Institute (Sales ¥ 112 M)
@ アプリックスIPホールディングス (Sales ¥ 2 B)
@ ブイシンク (Sales ¥ 255 M)
@ INSPIRE (Sales ¥ 46 M)
@ VLC HOLDINGS (Sales ¥ 88 M)
Sponsored Link


関連する株式投資情報

EDIUNET Caution

*Financial data might be different from the actual one. Please confirm the original, and read Caution.

*This site has obtained the information from the FSA's EDINET, Tokyo Stock Exchange's TDnet and Pay statistical data services, Fukuoka stock Exchange's Stock market capitalization, Center for Spatial Information Science's CSV Geocoding Service. The copyright of the information belongs to each corporation etc. .

▲ Go to the top ▲

  1. Guide
  2. Mobile
  3. Tablet
  4. Japanese
`EDIUNET` Copyright©2006-2024 `MAバンク` (0.060 sec.)